This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

BC-Business News Digest

AP photos.

â¿¿ OIL PRICES â¿¿ The price of oil recoups steep morning losses after a government report shows U.S. crude supplies grew a bit less than expected last week.

â¿¿ GEITHNER-FOREIGN RELATIONS â¿¿ Timothy Geithner is joining the Council on Foreign Relations in New York, his first public move since stepping down as Treasury Secretary last month.

â¿¿ OBAMA-INTERIOR â¿¿ President Barack Obama has picked the head of outdoor gear company REI, Sally Jewell, as secretary of Interior.



WASHINGTON â¿¿ The use of lithium ion batteries to power aircraft systems isn't necessarily unsafe despite a battery fire in one Boeing 787 Dreamliner and smoke in another, but manufacturers need to build in reliable safeguards, the nation's top aviation safety investigator says. By Joan Lowy.

AP photo.


â¿¿ UNITED AIRLINES-787S â¿¿ United Airlines is taking the troubled Boeing 787 out of its flying plans for the rest of this month.



LOS ANGELES â¿¿ Visa says its profit jumped 25 percent in the last three months of 2012 as consumers racked up more credit card debt and used their debit cards more often. By Business Writer Alex Veiga.

â¿¿ LUXEMBOURG-EARNS-ARCELORMITTAL â¿¿ ArcelorMittal, the world's largest steel maker, posts a nearly $4 billion fourth-quarter loss on charges related to its ailing European business and a drop in the value of its assets.

â¿¿ EARNS-RALPH LAUREN â¿¿ Ralph Lauren Corp. says profit rose 27 percent in its latest quarter as the designer clothing company's affluent customers spent generously during the winter holidays and trends improved in Europe. AP photo.


â¿¿ FAKE CANCER DRUG-FDA â¿¿ The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.


CVS Caremark's fourth-quarter earnings rise 6 percent, as new customers and Medicare prescription drug plans help its pharmacy benefits management business, while revenue from the chain's established drugstores grows. By Business Writer Tom Murphy.

3 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,945.66 -190.06 -1.05%
S&P 500 2,084.31 -16.73 -0.80%
NASDAQ 4,956.2690 -26.54 -0.53%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs